Management of coronary risk patients before anesthesia;Prise en charge des patients à risque coronaire avant une anesthésie

Presse Medicale

Volumn 38, Issue 7-8, 2009, Pages 1110-1119

  Piriou, Vincent ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AGRASTAT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; FLURBIPROFEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TIROFIBAN; UNCLASSIFIED DRUG;

ANESTHESIA INDUCTION; BLEEDING; CORONARY RISK; CORONARY STENT; DRUG EFFICACY; ELECTROCARDIOGRAM; EXERCISE TEST; FUNCTIONAL STATUS; HEART INFARCTION; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HEART SCINTISCANNING; HIGH RISK PATIENT; HUMAN; PATHOPHYSIOLOGY; PATIENT CARE; PERIOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PREOPERATIVE TREATMENT; SHORT SURVEY; STRESS ECHOCARDIOGRAPHY; SURGICAL RISK; THROMBOSIS;

ANESTHESIA, GENERAL; ELECTROCARDIOGRAPHY; HEMORRHAGE; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PLATELET AGGREGATION INHIBITORS; PREOPERATIVE CARE; RISK FACTORS; THROMBOSIS;

EID: 67649649894     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2008.08.013     Document Type: Short Survey

References (55)

1. Feringa H.H., Karagiannis S.E., Vidakovic R., Elhendy A., ten Cate F.J., Noordzij P.G., et al. The prevalence and prognosis of unrecognized myocardial infarction and silent myocardial ischemia in patients undergoing major vascular surgery. Coron Artery Dis 18 (2007) 571-576
2. Mantilla C.B., Horlocker T.T., Schroeder D.R., Berry D.J., and Brown D.L. Frequency of myocardial infarction, pulmonary embolism, deep venous thrombosis, and death following primary hip or knee arthroplasty. Anesthesiology 96 (2002) 1140-1146
3. Ausset S., Auroy Y., Lambert E., Vest P., Plotton C., Rigal S., et al. Cardiac troponin I release after hip surgery correlates with poor long-term cardiac outcome. Eur J Anaesthesiol 25 (2008) 158-164
4. Rosencher N., Vielpeau C., Emmerich J., Fagnani F., and Samama C.M. Venous thromboembolism and mortality after hip fracture surgery: the ESCORTE study. J Thromb Haemost 3 (2005) 2006-2014
5. Badner N.H., Knill R.L., Brown J.E., Novick T.V., and Gelb A.W. Myocardial infarction after noncardiac surgery. Anesthesiology 88 (1998) 572-578
6. Le Manach Y., Perel A., Coriat P., Godet G., Bertrand M., and Riou B. Early and delayed myocardial infarction after abdominal aortic surgery. Anesthesiology 102 (2005) 885-891
7. Landesberg G., Shatz V., Akopnik I., Wolf Y.G., Mayer M., Berlatzky Y., et al. Association of cardiac troponin, CK-MB, and postoperative myocardial ischemia with long-term survival after major vascular surgery. J Am Coll Cardiol 42 (2003) 1547-1554
8. Dawood M.M., Gutpa D.K., Southern J., Walia A., Atkinson J.B., and Eagle K.A. Pathology of fatal perioperative myocardial infarction: implications regarding pathophysiology and prevention. Int J Cardiol 57 (1996) 37-44
9. Poldermans D., Boersma E., Bax J.J., Kliffen M., van Urk H., van de Ven L., et al. Correlation of location of acute myocardial infarct after noncardiac vascular surgery with preoperative dobutamine echocardiographic findings. Am J Cardiol 88 1413-4 (2001) A6
10. Lee T.H., Marcantonio E.R., Mangione C.M., Thomas E.J., Polanczyk C.A., Cook E.F., et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 100 (1999) 1043-1049
11. Fleisher L.A., Beckman J.A., Brown K.A., Calkins H., Chaikof E., Fleischmann K.E., et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American college of cardiology/american heart association task force on practice guidelines (Writing committee to revise the 2002 guidelines on perioperative cardiovascular evaluation for noncardiac surgery): developed in collaboration with the American society of echocardiography, American society of nuclear cardiology, Heart rhythm society, society of cardiovascular anesthesiologists, Society for cardiovascular angiography and interventions, Society for vascular medicine and biology, and Society for vascular surgery. Circulation 116 (2007) e418-e499
12. Welten G.M., Schouten O., van Domburg R.T., Feringa H.H., Hoeks S.E., Dunkelgrun M., et al. The influence of aging on the prognostic value of the revised cardiac risk index for postoperative cardiac complications in vascular surgery patients. Eur J Vasc Endovasc Surg 34 (2007) 632-638
13. Beattie W.S., Abdelnaem E., Wijeysundera D.N., and Buckley D.N. A meta-analytic comparison of preoperative stress echocardiography and nuclear scintigraphy imaging. Anesth Analg 102 (2006) 8-16
14. Kertai M.D., Boersma E., Sicari R., L'Italien G.J., Bax J.J., Roelandt J.R., et al. Which stress test is superior for perioperative cardiac risk stratification in patients undergoing major vascular surgery?. Eur J Vasc Endovasc Surg 24 (2002) 222-229
15. Kertai M.D., Boersma E., Bax J.J., Heijenbrok-Kal M.H., Hunink M.G., L'Talien G.J., et al. A meta-analysis comparing the prognostic accuracy of six diagnostic tests for predicting perioperative cardiac risk in patients undergoing major vascular surgery. Heart 89 (2003) 1327-1334
16. McFalls E.O., Ward H.B., Moritz T.E., Goldman S., Krupski W.C., Littooy F., et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 351 (2004) 2795-2804
17. Ward H.B., Kelly R.F., Thottapurathu L., Moritz T.E., Larsen G.C., Pierpont G., et al. Coronary artery bypass grafting is superior to percutaneous coronary intervention in prevention of perioperative myocardial infarctions during subsequent vascular surgery. Ann Thorac Surg 82 (2006) 795-801
18. Albaladejo P., Marret E., Piriou V., and Samama C.M. Gestion du traitement antiplaquettaire oral chez les patients porteurs d'endoprotheses coronaires. Ann Fr Anesth Reanim 25 (2006) 796-798
19. London M.J., Zaugg M., Schaub M.C., and Spahn D.R. Perioperative beta-adrenergic receptor blockade: physiologic foundations and clinical controversies. Anesthesiology 100 (2004) 170-175
20. Multicenter study of perioperative ischemia research group, Mangano D.T., Layug E.L., Wallace A., and Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med 335 (1996) 1713-1720
21. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group, Poldermans D., Boersma E., Bax J.J., Thomson I.R., van de Ven L.L., and Blankensteijn J.D. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med 341 (1999) 1789-1794
22. Brady A.R., Gibbs J.S., Greenhalgh R.M., Powell J.T., and Sydes M.R. Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. J Vasc Surg 41 (2005) 602-609
23. Yang H., Raymer K., Butler R., Parlow J., and Roberts R. The effects of perioperative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J 152 (2006) 983-990
24. Juul A.B., Wetterslev J., Kofoed-Enevoldsen A., Callesen T., Jensen G., and Gluud C. The Diabetic postoperative mortality and morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery. Am Heart J 147 (2004) 677-683
25. Lindenauer P.K., Pekow P., Wang K., Mamidi D.K., Gutierrez B., and Benjamin E.M. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 353 (2005) 349-361
26. Devereaux P.J., Yang H., Yusuf S., Guyatt G., Leslie K., Villar J.C., et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 371 (2008) 1839-1847
27. Fleisher L.A., and Poldermans D. Perioperative beta blockade: where do we go from here?. Lancet 371 (2008) 1813-1814
28. Sear J.W., Giles J.W., Howard-Alpe G., and Foex P. Perioperative beta-blockade, 2008: what does POISE tell us, and was our earlier caution justified?. Br J Anaesth 101 (2008) 135-138
29. Schouten O., Poldermans D., Visser L., Kertai M.D., Klein J., and van Urk H. Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: rationale and design of the DECREASE-IV study. Am Heart J 148 (2004) 1047-1052
30. Monk T.G., Saini V., Weldon B.C., and Sigl J.C. Anesthetic management and one-year mortality after noncardiac surgery. Anesth Analg 100 (2005) 4-10
31. Piriou V., Marret E., Albaladejo P., and Samain E. Un pavé dans la mare des bétabloquants. Ann Fr Anesth Reanim 27 (2008) 197-199
32. Kapoor A.S., Kanji H., Buckingham J., Devereaux P.J., and McAlister F.A. Strength of evidence for perioperative use of statins to reduce cardiovascular risk: systematic review of controlled studies. BMJ 333 (2006) 1149
33. Le Manach Y., Coriat P., Collard C.D., and Riedel B. Statin therapy within the perioperative period. Anesthesiology 108 (2008) 1141-1146
34. Durazzo A.E., Machado F.S., Ikeoka D.T., De Bernoche C., Monachini M.C., and Puech-Leao P. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg 39 (2004) 967-976
35. Hoeks S.E., Scholte O.P., Reimer W.J., van Urk H., Jorning P.J., Boersma E., Simoons M., et al. Increase of 1-year mortality after perioperative beta-blocker withdrawal in endovascular and vascular surgery patients. Eur J Vasc Endovasc Surg 33 (2007) 13-19
36. Le Manach Y., Godet G., Coriat P., Martinon C., Bertrand M., Fleron M.H., et al. The impact of postoperative discontinuation or continuation of chronic statin therapy on cardiac outcome after major vascular surgery. Anesth Analg 104 (2007) 1326-1333
37. Brabant S.M., Bertrand M., Eyraud D., Darmon P.L., and Coriat P. The hemodynamic effects of anesthetic induction in vascular surgical patients chronically treated with angiotensin II receptor antagonists. Anesth Analg 89 (1999) 1388-1392
38. Licker M., Schweizer A., Hohn L., Farinelli C., and Morel D.R. Cardiovascular responses to anesthetic induction in patients chronically treated with angiotensin-converting enzyme inhibitors. Can J Anaesth 47 (2000) 433-440
39. Coriat P., Richer C., Douraki T., Gomez C., Hendricks K., Giudicelli J.F., et al. Influence of chronic angiotensin-converting enzyme inhibition on anesthetic induction. Anesthesiology 81 (1994) 299-307
40. Comfere T., Sprung J., Kumar M.M., Draper M., Wilson D.P., Williams B.A., et al. Angiotensin system inhibitors in a general surgical population. Anesth Analg 100 (2005) 636-644
41. Bertrand M., Godet G., Meersschaert K., Brun L., Salcedo E., and Coriat P. Should the angiotensin II antagonists be discontinued before surgery?. Anesth Analg 92 (2001) 26-30
42. Poldermans D., Schouten O., Vidakovic R., Bax J.J., Thomson I.R., Hoeks S.E., et al. A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study. J Am Coll Cardiol 49 (2007) 1763-1769
43. Poldermans D., Bax J.J., Schouten O., Neskovic A.N., Paelinck B., and Rocci G. Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control?. J Am Coll Cardiol 48 (2006) 964-969
44. Beving H., Zhao C., Albage A., and Ivert T. Abnormally high platelet activity after discontinuation of acetylsalicylic acid treatment. Blood Coagul Fibrinolysis 7 (1996) 80-84
45. Sibon I., and Orgogozo J.M. Antiplatelet drug discontinuation is a risk factor for ischemic stroke. Neurology 62 (2004) 1187-1189
46. Collet J.P., Montalescot G., Blanchet B., Tanguy M.L., Golmard J.L., Choussat R., et al. Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes. Circulation 110 (2004) 2361-2367
47. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 2000; 355:1295-302.
48. Société francophone de médecine buccale et de chirurgie buccale. Prise en charge des patients sous agents antiplaquettaires en odontostomatologie. Médecine buccale et chirurgie buccale 2005; 11:55-76.
49. http://www.sfed.org/.
50. Fleron M.H., Dupuis M., Mottet P., Le Feuvre C., and Godet G. Chirurgie générale et endoprothèse coronaire: pensez au sirolimus!. Ann Fr Anesth Reanim 22 (2003) 733-735
51. McFadden E.P., Stabile E., Regar E., Cheneau E., Ong A.T., Kinnaird T., et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 364 (2004) 1519-1521
52. Brichon P.Y., Boitet P., Dujon A., Mouroux J., Peillon C., Riquet M., et al. Perioperative in-stent thrombosis after lung resection performed within 3 months of coronary stenting. Eur J Cardiothorac Surg 30 (2006) 793-796
53. Iakovou I., Schmidt T., Bonizzoni E., Ge L., Sangiorgi G.M., Stankovic G., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. Jama 293 (2005) 2126-2130
54. Riddell J.W., Chiche L., Plaud B., and Hamon M. Coronary stents and noncardiac surgery. Circulation 116 (2007) e378-e382
55. Gurbel P.A., DiChiara J., and Tantry U.S. Antiplatelet therapy after implantation of drug-eluting stents: duration, resistance, alternatives, and management of surgical patients. Am J Cardiol 100 (2007) 18M-25M